Pfenex Expression Technology Prima RNApols PeliCRM197
  • About
    • Leadership & Team
    • Our Heritage
    • Careers
  • Offerings
    • Protein Expression
    • mRNA Manufacturing Solutions
    • CRM197
  • Insights
    • Press Releases
    • Resource Center
  • Work With Us
Intravacc and Primrose Bio Announce Partnership to Enhance Conjugate Vaccine Development

Intravacc and Primrose Bio Announce Partnership to Enhance Conjugate Vaccine Development

by Primrose Bio | Mar 28, 2024 | Featured, Press

The companies will leverage their combined experience in the development of conjugate vaccines for their clients  Primrose Bio will supply its industry-leading carrier protein, PeliCRM197®, for vaccine development Intravacc has IP and know how in vaccine...
Next Entries »

About
Leadership & Team
Our Heritage
Careers

Therapeutic Protein Solutions
Pfenex Expression Technology®
Pfast™ Feasibility Program
PeliCRM197®
Synthetic Biology

Nucleic Acid Therapeutic Solutions
mRNA Manufacturing Solutions
Prima RNApols™
Evaluate Prima RNApols™
Enzymatic Oligonucleotide Synthesis

Insights

Contact

Terms and Conditions

Privacy Policy

EU Online Dispute Resolution

  • Follow
SIGN UP FOR OUR LATEST NEWS